Intranasal Steroids and the Nasal Ocular Response
Phase 4
Completed
- Conditions
- Seasonal Allergic Rhinitis
- First Posted Date
- 2007-05-16
- Last Posted Date
- 2013-06-03
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 20
- Registration Number
- NCT00473915
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Recruiting
- Conditions
- SarcoidosisInterstitial Lung DiseasesConnective Tissue DisorderIdiopathic Pulmonary Fibrosis
- First Posted Date
- 2007-05-07
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 4000
- Registration Number
- NCT00470327
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer
Phase 2
Completed
- Conditions
- Head and Neck Cancer
- Interventions
- Radiation: Accelerated fraction radiotherapy with concomitant boostRadiation: Twice-daily radiation
- First Posted Date
- 2007-05-02
- Last Posted Date
- 2019-10-09
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 110
- Registration Number
- NCT00468169
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Cytokine Profiles in Children With Obstructive Sleep Apnea
Not Applicable
Completed
- Conditions
- Obstructive Sleep Apnea Syndrome
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 40
- Registration Number
- NCT00456573
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Systemic Steroids Plus Antibiotics in Sleep Apnea Syndrome in Children
Phase 4
Terminated
- Conditions
- Obstructive Sleep Apnea Syndrome
- First Posted Date
- 2007-04-04
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 4
- Registration Number
- NCT00456339
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
GI Reflux in Lung Transplant and Its Relationship to Chronic Rejection
Completed
- Conditions
- Gastroesophageal Reflux
- First Posted Date
- 2007-04-03
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 20
- Registration Number
- NCT00455078
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Voriconazole as Prophylactic Therapy in Lung Transplant Recipients
Phase 4
Terminated
- Conditions
- Infection
- First Posted Date
- 2007-04-03
- Last Posted Date
- 2013-02-06
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 20
- Registration Number
- NCT00455364
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
- First Posted Date
- 2007-03-27
- Last Posted Date
- 2016-08-24
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 12
- Registration Number
- NCT00452218
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies
- First Posted Date
- 2007-03-20
- Last Posted Date
- 2013-06-12
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 34
- Registration Number
- NCT00449280
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Early Indicators of Chronic Rejection in Lung Transplant
Terminated
- Conditions
- Chronic Rejection in Lung TransplantCytokine Production in Bos Post Lung Transplant
- First Posted Date
- 2007-03-20
- Last Posted Date
- 2016-09-20
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 120
- Registration Number
- NCT00449332
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath